Immunocore Holdings share price logo

Immunocore Holdings

NASDAQ: IMCR

Small Cap

$29.39

+0.30

(+1.03%)

as on

Immunocore Holdings Stock Performance

as on October 12, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $29.03
    $29.73
    downward going graph

    1.22%

    Downside

    1.16%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $27.56
    $40.71
    downward going graph

    6.24%

    Downside

    38.53%

    Upside

    downward going graph

Immunocore Holdings share price movements today

Previous Close
$29.09
Open
$29.06
Volume
453.1K
Market Cap
$1.5B
Day's Low - High
$29.03 - $29.73
52 Week Low - High
$27.56 - $40.71

Immunocore Holdings Historical Returns

1 Month Return
-9.85 %
3 Month Return
-8.01 %
1 Year Return
-9.29 %
3 Year Return
-39.15 %
5 Year Return
-22.58 %

Immunocore Holdings Stock Fundamentals & Key Indicators

Check Immunocore Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

-0.1844

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

1.50%

PE Ratio (TTM)

-163.01

Industry PE ratio

-6.44

PEG Ratio

-5.15

EBITDA

16.4M

Revenue (TTM)

403.7M

Profit Margin

98.85%

Return On Equity TTM

-2.35%

Immunocore Holdings vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immunocore Holdings with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Immunocore Holdings image
Immunocore Holdings
Buy$1.5B-22.58%-163.0198.85%0.00%
Moderna image
Moderna
Neutral$89.8B-27.68%-28.20-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$129.3B183.05%29.4586.04%0.00%
Regeneron image
Regeneron
Buy$76.9B37.12%17.8384.86%0.50%

Stock Returns calculator for Immunocore Holdings Stock including INR - Dollar returns

The Immunocore Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Immunocore Holdings investment value today

Current value as on today

₹97,969

Returns

-₹2,031

(-2.03%)

Returns from Immunocore Holdings Stock

-₹9,290 (-9.29%)

Dollar Impact

₹7,259 (+7.26%)

Analyst Recommendation on Immunocore Holdings Stock

Based on 5 analysts

BUY

60.00%

Buy

40.00%

Hold

0.00%

Sell

Based on 5 analysts, 60% of analysts recommend a 'BUY' rating for Immunocore Holdings. Average target price of $62.73

Immunocore Holdings Share Price Target

Get share price movements and forecasts by analysts on Immunocore Holdings.

What analysts predicted

53.15%UPSIDE

Target Price

$62.73

Current Price

$29.39

Analyzed by

5 Analysts

High

$100

Target

$62.73

Low

$35

Immunocore Holdings target price $62.73, a slight upside of 53.15% compared to current price of $29.39. According to 5 analysts rating.

Indian Investors' Interest in Immunocore Holdings Stock

Search interest for Immunocore Holdings Stock has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-47% versus previous 30 day period

Immunocore Holdings Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
70
75
80
84
93
97
103
77
106
115
Gross Profit
70
73
79
83
93
96
103
74
106
114
Operating Income
-26
-16
-8
-19
-3
-14
-7
-14
7
-2
EBITDA
-19
-5
10
-15
9
-6
4
-7
16
3
Interest Expense
3
3
3
6
3
3
3
3
2
3
Depreciation
1
0
1
1
0
0
0
0
0
1
Income Before Tax
-24
-10
6
-24
6
-9
0
-11
13
0
Income Tax Expense
0
1
-2
-1
1
0
0
10
0
0
Net Income
-24
-11
8
-23
5
-10
0
-22
12
0
Net Profit Margin
99.65%
97.74%
99.44%
99.61%
99.11%
98.94%
99.51%
96.61%
99.59%
99.06%

Immunocore Holdings Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
14
23
25
30
27
144
197
247
297
Gross Profit
14
23
-74
-44
27
138
196
242
291
Operating Income
-67
-93
-118
-86
-129
-42
-47
-56
-33
EBITDA
-64
-86
-108
-79
-
-
-40
-37
0
Interest Expense
-
0
3
3
5
5
4
18
12
Depreciation
4
6
9
9
-
-
3
4
2
Income Before Tax
-64
-88
-81
-87
-133
-33
-48
-42
-14
Income Tax Expense
15
-16
22
-13
0
9
-4
-1
12
Net Income
-49
-71
-103
-74
-133
-43
-43
-40
-26
Net Profit Margin
100.00%
100.00%
-289.54%
-148.42%
100.00%
96.33%
99.58%
97.76%
97.91%

Immunocore Holdings Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-24
-11
8
-23
5
-10
0
-30
12
0
Operating Cash Flow
-4
23
21
-13
0
25
-4
-32
-13
-5
Investing Cash Flow
0
-350
0
-3
9
-30
5
0
4
0
Financing Cash Flow
396
0
0
-51
2
3
1
4
0
15
Change in Cash
390
-327
32
-82
21
11
10
-30
-15
15

Immunocore Holdings Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-49
-71
-103
-74
-180
-52
-34
-51
-26
Operating Cash Flow
-61
-16
-101
-60
-143
-49
2
26
-7
Investing Cash Flow
-9
58
-4
0
-1
-2
-4
-355
-12
Financing Cash Flow
19
0
55
115
288
145
27
343
9
Change in Cash
-52
41
-50
55
144
81
31
13
8

Global Institutional Holdings in Immunocore Holdings

Check out the Institutions with significant holdings in Immunocore Holdings.

Funds
Holdings
VANGUARD SPECIALIZED FUNDS
8.25%
Theofanis Kolokotrones
7.06%
VANGUARD HORIZON FUNDS
4.71%
Fidelity Mt. Vernon Street Trust
3.54%
PRIMECAP Odyssey Funds
2.16%
See all

Immunocore Holdings News & Key Events

  • img

    Today's Timeline - 14 September

    Mon, 05:20 PM

    -

    Immunocore completes enrollment of 540 patients in Phase 3 TEBE-AM trial for KIMMTRAK in advanced melanoma.

Insights on Immunocore Holdings

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 77.42M → 115.92M (in $), with an average increase of 17.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.6% return, outperforming this stock by 747.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 123.3% return, outperforming this stock by 162.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, IMCR stock has moved down by -9.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 12.97M → -808.0K (in $), with an average decrease of 106.2% per quarter

About Immunocore Holdings

Immunocore Holdings plc, a biotechnology firm established in 1999 and based in Abingdon, United Kingdom, has reached the commercial stage in its mission to create pioneering immunotherapies. The company's development pipeline addresses a range of serious conditions, including various cancers, infectious diseases, and autoimmune disorders. Its currently marketed product, KIMMTRAK, offers a treatment option for patients with uveal melanoma that is either unresectable or has metastasized. Within oncology, Immunocore is progressing IMC-C103C through early-stage (Phase I/II) dose escalation trials for several solid tumor types, notably non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers. Another key oncology program, IMC-F106C, is also in Phase I/II dose escalation studies for a diverse array of solid malignancies, including NSCLC, small-cell lung, endometrial, ovarian, cutaneous melanoma, and breast cancers. For infectious diseases, the company is advancing IMC-I109V in Phase I/II clinical trials for chronic hepatitis B virus, alongside IMC-M113V, which is undergoing preclinical development for human immunodeficiency virus (HIV). Additionally, Immunocore is developing novel therapeutic candidates designed to deliver precise, targeted immunosuppression as a treatment strategy for autoimmune conditions.
OrganisationImmunocore Holdings
Headquarters92 Park Drive, Abingdon, OX, OX14 4RY, GB
IndustryBiotechnology
CEOBahija Jallal

Key Management of Immunocore Holdings

Name

Title

Mr. Ryan Baker

Vice President of Investor Relations

Ms. Elizabeth Varki Jobes Esq., J.D.

Chief Compliance Officer

Mr. Sébastien Desprez

Vice President of Communications

Mr. Travis Alan Coy M.B.A.

CFO, Executive VP & Head of Corporate Development

Dr. Kripa Ram Ph.D.

Executive VP & Chief Operating Officer

Ms. Annelise Vuidepot Ph.D.

Chief Science and Technology Officer & Milton Park Site Head

Mr. Sean D. Buckley

VP & Chief Information Officer

Ms. Lily Margaret Hepworth

Executive VP, General Counsel & Company Secretary

Dr. Bahija Jallal Ph.D.

CEO & Executive Director

Mr. John Goll III

SVP, Finance & Chief Accounting Officer

FAQs

What is Immunocore Holdings share price today?

Immunocore Holdings share price today is $29.39 as on at the close of the market. Immunocore Holdings share today touched a day high of $29.73 and a low of $29.03.

What is the 52 week high and 52 week low for Immunocore Holdings share?

Immunocore Holdings share touched a 52 week high of $40.71 on and a 52 week low of $27.56 on . Immunocore Holdings stock price today i.e. is closed at $29.39,which is 27.81% down from its 52 week high and 6.66% up from its 52 week low.

What is Immunocore Holdings's market capitalisation today?

Immunocore Holdings market capitalisation is $0.00T as on .

How to invest in Immunocore Holdings Stock (IMCR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immunocore Holdings on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Immunocore Holdings Stock (IMCR) from India?

Indian investors can start investing in Immunocore Holdings (IMCR) shares with as little as ₹95.76000213623047 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.60 in Immunocore Holdings stock (as per the Rupee-Dollar exchange rate as on ). Based on Immunocore Holdings share’s latest price of $29.39 as on October 12, 2026 at 8:46 am IST, you will get 0.3403 shares of Immunocore Holdings. Learn more about fractional shares .

What are the returns that Immunocore Holdings has given to Indian investors in the last 5 years?

Immunocore Holdings stock has given -22.58% share price returns and 28.2% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?